相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
Scott D. Brown et al.
GENOME RESEARCH (2014)
Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer
Eric Tran et al.
SCIENCE (2014)
Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer
Anneke Neumann et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
Dan A. Landau et al.
CELL (2013)
Lessons from the Cancer Genome
Levi A. Garraway et al.
CELL (2013)
The cancer antigenome
Bianca Heemskerk et al.
EMBO JOURNAL (2013)
HLA ligandome tumor antigen discovery for personalized vaccine approach
Hans-Georg Rammensee et al.
EXPERT REVIEW OF VACCINES (2013)
Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells
Ute E. Burkhardt et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
Nienke van Rooij et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Mutated PPP1R3B Is Recognized by T Cells Used To Treat a Melanoma Patient Who Experienced a Durable Complete Tumor Regression
Yong-Chen Lu et al.
JOURNAL OF IMMUNOLOGY (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
Paul F. Robbins et al.
NATURE MEDICINE (2013)
Getting Personal with Neoantigen-Based Therapeutic Cancer Vaccines
Nir Hacohen et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Targeting the Epidermal Growth Factor Receptor in Solid Tumor Malignancies
Mette K. Nedergaard et al.
BIODRUGS (2012)
Exploiting the Mutanome for Tumor Vaccination
John C. Castle et al.
CANCER RESEARCH (2012)
Activation of multiple cancer pathways and tumor maintenance function of the 3q amplified oncogene FNDC3B
Chunlin Cai et al.
CELL CYCLE (2012)
Mutated BCR-ABL Generates Immunogenic T-cell Epitopes in CML Patients
Ann Cai et al.
CLINICAL CANCER RESEARCH (2012)
Re: Antitumor Activity and Safety of Tivozanib (AV-951) in a Phase II Randomized Discontinuation Trial in Patients with Renal Cell Carcinoma Editorial Comment
Samir S. Taneja
JOURNAL OF UROLOGY (2012)
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita et al.
NATURE (2012)
Expression of tumour-specific antigens underlies cancer immunoediting
Michel DuPage et al.
NATURE (2012)
Absolute quantification of somatic DNA alterations in human cancer
Scott L. Carter et al.
NATURE BIOTECHNOLOGY (2012)
Tumor Heterogeneity and Personalized Medicine
Dan L. Longo
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Many Tumors in One: A Daunting Therapeutic Prospect
Chibawanye I. Ene et al.
CANCER CELL (2011)
Therapeutic vaccination against human papilloma virus induced malignancies
Sjoerd H. van der Burg et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Prediction of epitopes using neural network based methods
Claus Lundegaard et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Machine learning competition in immunology - Prediction of HLA class I binding peptides
Guang Lan Zhang et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Lili Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cloning of a Novel Protein Interacting with BRS-3 and Its Effects in Wound Repair of Bronchial Epithelial Cells
Hui Jun Liu et al.
PLOS ONE (2011)
Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion
Wandi Zhang et al.
CLINICAL CANCER RESEARCH (2010)
Melanomas acquire resistance toB-RAF(V600E) inhibition by RTK or N-RAS upregulation
Ramin Nazarian et al.
NATURE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2010)
Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 cases
Ilaria Del Giudice et al.
BLOOD (2009)
HLA ligand profiles of primary renal cell carcinoma maintained in metastases
Juliane Sarah Stickel et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Development of Tumor-Reactive T Cells After Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for Chronic Lymphocytic Leukemia
Tetsuya Nishida et al.
CLINICAL CANCER RESEARCH (2009)
Evaluation of MHC class I peptide binding prediction servers: Applications for vaccine research
Hong Huang Lin et al.
BMC IMMUNOLOGY (2008)
Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology
Graca A. M. Dores et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Unique human tumor antigens: Immunobiology and use in clinical trials
Giorgio Parmiani et al.
JOURNAL OF IMMUNOLOGY (2007)
Unique tumor antigens: Evidence for immune control of genome integrity and immunogenic targets for T cell-mediated patient-specific immunotherapy
Marialuisa Sensi et al.
CLINICAL CANCER RESEARCH (2006)
The response of autologous T cells to a human melanoma is dominated by mutated neoantigens
V Lennerz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Alms1-disrupted mice recapitulate human Alstrom syndrome
GB Collin et al.
HUMAN MOLECULAR GENETICS (2005)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Molecules and mechanisms of the graft-versus-leukaemia effect
M Bleakley et al.
NATURE REVIEWS CANCER (2004)
Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes
S Baskar et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Induction of primary NY-ESO-1 immunity:: CD8+T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+cancers
E Jäger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)